Search Results - "PAPI, C."

Adaptation and psychometric properties of the Italian version of the Non-Motor Symptoms Questionnaire for Parkinson's disease.

Authors: Cova, I. Battista, M. Vanacore, N. et al.

Source: Neurological Sciences. Apr2017, Vol. 38 Issue 4, p673-678. 6p.

Subjects: Psychometrics, Parkinson's disease, Questionnaires, Validation therapy, Comorbidity, Parkinson's disease diagnosis, Analysis of variance, Comparative studies, Research methodology, Medical cooperation, Psychological tests, Research, Research evaluation, Evaluation research

Geographic Terms: Italy

Early versus late surgery for ileo-caecal Crohn’s disease.

Authors: ARATARI, A. PAPI, C. LEANDRO, G. et al.

Source: Alimentary Pharmacology & Therapeutics. Nov2007, Vol. 26 Issue 10, p1303-1312. 10p. 3 Charts, 3 Graphs.

Budesonide in the treatment of Crohn’s disease: a meta-analysis.

Authors: Papi, C. Luchetti, R. Gili, L. et al.

Source: Alimentary Pharmacology & Therapeutics. Nov2000, Vol. 14 Issue 11, p1419-1428. 10p.

Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic aetiology.

Authors: Iorio, R. Damato, V. Spagni, G. et al.

Source: European Journal of Neurology. Oct2020, Vol. 27 Issue 10, p2062-2071. 10p.

Subjects: Anti-NMDA receptor encephalitis, Immunoglobulin G, Cerebrospinal fluid, Encephalitis, Cell surface antigens, Temporal lobe

Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine

Authors: Papi, C. Aratari, A. Tornatore, V. et al.

Source: Journal of Crohn's & Colitis. Jun2009, Vol. 3 Issue 2, p109-114. 6p.

P291 Clinical course of perianal fistulas in Crohn's disease: a retrospective study

Authors: Alessandroni, L. Papi, C. Papparella, L.G. et al.

Source: Journal of Crohn's & Colitis. Feb2013 Supplement, Vol. 7, pS125-S126. 0p.

P186 - Long-term prevention of post-operative recurrence in Crohn's disease is not affected by mesalamine

Authors: Aratari, A. Papi, C. Tornatore, V. et al.

Source: Journal of Crohn's & Colitis. Feb2009, Vol. 3 Issue 1, pS83-S84. 0p.

Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitis: a metaanalysis.

Authors: Catarci, M. Papi, C.

Source: Surgical Endoscopy & Other Interventional Techniques. Mar2007, Vol. 21 Issue 3, p488-488. 1p.

Tofacitinib in active ulcerative colitis.

Authors: Cottone M Orlando A Papi C et al.

Source: New England Journal of Medicine. 11/15/2012, Vol. 367 Issue 20, p1960-1961. 3p.

Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease.

Authors: Bianchi, M. Festa, V. Moretti, A. et al.

Source: Alimentary Pharmacology & Therapeutics. Apr2011, Vol. 33 Issue 8, p902-910. 9p. 1 Diagram, 5 Charts, 3 Graphs.

Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis.

Authors: Viscido, A. Habib, F. I. Kohn, A. et al.

Source: Alimentary Pharmacology & Therapeutics. May2003, Vol. 17 Issue 10, p1263-1271. 9p. 2 Charts.

Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.

Authors: Caprilli, R. Cottone, M. Tonelli, F. et al.

Source: Alimentary Pharmacology & Therapeutics. Feb2003, Vol. 17 Issue 4, p517-523. 7p. 2 Charts.

Infliximab and refractory ulcerative colitis

Authors: Caprilli, R. Aratari, A. Papi, C.

Source: Journal of Crohn's & Colitis. Feb2009, Vol. 3 Issue 1, p44-44. 1p.

Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study.

Authors: Alessandroni, L. Kohn, A. Cosintino, R. et al.

Source: Techniques in Coloproctology. Dec2011, Vol. 15 Issue 4, p407-412. 6p.

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study.

Authors: Biancone, L. Orlando, A. Kohn, A. et al.

Source: Gut (0017-5749). Feb2006, Vol. 55 Issue 2, p228-233. 6p.

Hepatobiliary Alterations in Patients with Inflammatory Bowel Disease: A Multicenter Study.

Authors: RIEGLER, G. D'INCÀ, R. STURNIOLO, G. C. et al.

Source: Scandinavian Journal of Gastroenterology. 4/1/98, Vol. 33 Issue 1, p93-98. 6p.

509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis.

Authors: Bezzerri, V. Gentili, V. Boni, C. et al.

Source: Journal of Cystic Fibrosis. 2022 Supplement 2, Vol. 21, pS287-S287. 1p.

P472 SOFA SCORE AND NEUTROPHIL COUNT ARE STRONG PREDICTIVE FACTORS OF MORTALITY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS WHO DEVELOP ACUTE-ON-CHRONIC LIVER FAILURE.

Authors: Agiasotelli, D.E. Alexopoulou, A. Vasilieva, L. et al.

Source: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS226-S226. 1p.

P292 Clinical characteristics of inflammatory bowel disease may influence the cancer risk when using immunomodulators: incident cases of cancer in a multicenter case-control study

Authors: Petruzziello, C. Armuzzi, A. Kohn, A. et al.

Source: Journal of Crohn's & Colitis. Feb2013 Supplement, Vol. 7, pS126-S126. 1p.

P268 A survey about the use of thiopurines for inflammatory bowel diseases among Italian gastroenterologists

Authors: Saibeni, S. Kohn, A. Meucci, G. et al.

Source: Journal of Crohn's & Colitis. Feb2012 Supplement 1, Vol. 6, pS116-S116. 1p.